Markwell Clarizio LLP

Federal Court Makes Rare Holding that Patent Claims are Invalid for Ambiguity

Co-authored by Emily PapsinThe Federal Court recently held (per McHaffie J.) that the impugned claims of two related patents for an additive manufacturing process (3D printing) were invalid and not infringed because an essential element (“depletion layer”) was ambiguous. Tekna Plasma Systems Inc. v. AP&C Advanced Powders & Coatings Inc., 2024 FC 871 Background This […]

Federal Court Makes Rare Holding that Patent Claims are Invalid for Ambiguity Read More »

Court Overturns TMOB Decision Based on New Evidence of Earlier and Continuous Use

The Federal Court (Tsimberis J.) recently held that the Applicant, F.I.A.L. Finanziaria Industrie Alto Lario, S.P.A. (“Applicant” or “Fial”) is entitled to register the trademark, GALPERTI pursuant to ss. 38(2)(c) and 16(1)(a) of the Trademarks Act (the “Act”) in an appeal of a decision of the Trademarks Opposition Board (“Board”) that had refused Fial’s application

Court Overturns TMOB Decision Based on New Evidence of Earlier and Continuous Use Read More »

Supreme Court of Canada Dismisses Application for Leave in Apotex Inc. v. Janssen Inc. et al., 2024 FCA 9 and Pharmascience Inc. v. Janssen Inc. et al., 2024 FCA 10

On June 27, 2024, the Supreme Court of Canada dismissed the applications for leave to appeal in Apotex Inc. v. Janssen Inc. et al., 2024 FCA 9 and Pharmascience Inc. v. Janssen Inc. et al., 2024 FCA 10, both Federal Court of Appeal decisions pertaining to inducing infringement of a patented dosing regimen. We published

Supreme Court of Canada Dismisses Application for Leave in Apotex Inc. v. Janssen Inc. et al., 2024 FCA 9 and Pharmascience Inc. v. Janssen Inc. et al., 2024 FCA 10 Read More »

Federal Court Grants an Application to Add Inventors and an Owner to an Issued Patent

 On May 31, 2024, the Federal Court (Tsimberis J.) granted an application to correct the inventorship of an issued patent. The decision provides a clear explanation of the relevant legal principles (Patent Act, s. 52) and the type of evidence that must be led to obtain relief. Smith Sport Optics, Inc. v. Canada (Commissioner of

Federal Court Grants an Application to Add Inventors and an Owner to an Issued Patent Read More »

Court Dismisses Passing Off and Expungement Action After Summary Trial

This was a motion for summary trial in a passing off and expungement case between competitors in the mobile video game market. The Court (per Fuhrer J.) held that summary trial was an appropriate vehicle for deciding the Plaintiff’s claims for passing off and expungement of the Defendant’s registration – and that those claims were

Court Dismisses Passing Off and Expungement Action After Summary Trial Read More »

Federal Court Re-Iterates that the Fair Dealing Exception to Copyright Infringement is Fact Specific

On May 31, 2024, the Federal Court (Roy J) released its decision on the summary judgment motion brought by the Attorney General of Canada (“AGC”) on behalf of Parks Canada, in which he dismissed Blacklock’s Reporter’s (“BR”) copyright infringement action against the AGC. This matter is one of several related and contextually similar actions brought

Federal Court Re-Iterates that the Fair Dealing Exception to Copyright Infringement is Fact Specific Read More »

Red Maple Manufacturing Inc. v. Red Maple Bio Inc. 2024 FC 817

On May 29, 2024, the Federal Court (Whyte Nowak J.) granted Red Maple Manufacturing Inc.’s (the “Applicant”) appeal pursuant to subsection 56(1) of the Trademarks Act. The Applicant appealed a decision from the Trademarks Opposition Board (“the Board”) ordering the removal of certain goods from the Applicant’s Trademark Registration. Red Maple Manufacturing Inc. v. Red

Red Maple Manufacturing Inc. v. Red Maple Bio Inc. 2024 FC 817 Read More »

Parliamentary Committee Issues Report on PMPRB Reform. Calls for “Comprehensive Response” by the Government

Parliamentary Committee Issues Report on PMPRB Reform. Calls for “Comprehensive Response” by the Government On May 6, 2024, Canada’s Standing Committee on Health (“HESA”) issued a report containing “ten recommendations on how the Government of Canada can enable the Patented Medicine Prices Review Board (“PMPRB”) to more effectively carry out its mandate and implement its

Parliamentary Committee Issues Report on PMPRB Reform. Calls for “Comprehensive Response” by the Government Read More »

Markwell Clarizio LLP is a Contributor to the Chambers Life Sciences 2024 Global Practice Guide

Chambers and Partners has recently published its 2024 Life Sciences Global Practice Guide. Markwell Clarizio LLP is very pleased to have been invited to be the exclusive author of the Canadian sections of this comprehensive practice guide which is considered the “definitive global law guide offering comparative analysis from top ranked lawyers”. In the Canadian

Markwell Clarizio LLP is a Contributor to the Chambers Life Sciences 2024 Global Practice Guide Read More »